Datametrex signs two new feature films in Montreal | 2021-08-30 | Press Releases
Toronto, Ontario – (Newsfile Corp. – August 30, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has signed two (2) new service agreements for COVID-19 testing in Montreal with two Hollywood feature films.
The hyperinfectious Delta variant, which is significantly more contagious than the original COVID-19 variant, has been detected in around 100 countries around the world and is now the dominant variant globally, according to the US Centers for Disease Control. United.
As previously mentioned, film and television productions in Canada, including unions representing production staff, film crews and actors as well as Canadians in general, have a major concern regarding the Delta variant (B.1.617 variant. 2.), a hyper-contagious SARS. CoV-2 virus strain, which was first identified in India in October 2020.
Datametrex will continue to support Vancouver, Toronto and Montreal by providing critical COVID-19 test kits for actors, film crews and production support staff to prevent cluster outbreaks. Film and television production companies all support the continued use of security protocols, especially COVID-19 testing to keep production members and cast members healthy and safe while employed on sets and in production offices.
“The COVID-19 testing market in Montreal and across our network is an important business segment for Datametrex and we seek to remain steadfast in supporting the film industry with COVID testing and now with the Delta variant of the virus now. the dominant variant in the world, now is a good time to continue testing protocols to keep everyone working and staying healthy, ”said Marshall Gunter, CEO of Datametrex.
Datametrex AI Limited is a technology-driven company with exposure to artificial intelligence and machine learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that help businesses achieve their operational goals, including health and safety, with predictive and preventative technologies. By working with businesses to set a new standard for protocols through artificial intelligence and health diagnostics, the company is providing progressive solutions to support the supply chain.
For more information about Datametrex and other company information, please visit the Company’s website at www.datametrex.com.
For more information, please contact:
Marshall Gunter – CEO
Telephone: (514) 295-2300
Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
All statements included in this press release that deal with activities, events or developments that the Company expects, believes or anticipates will occur or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, its perception of historical trends, current conditions, expected future developments and other factors that it deems appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties which contribute to the possibility that predictions, forecasts, projections and other forward-looking statements may prove to be inaccurate, some of which are beyond the control of the Company. In particular, there is no guarantee that the parties will successfully negotiate and reach a definitive agreement on mutually acceptable terms or complete the Transaction in the manner contemplated herein, if any, that the due diligence of either satisfactory, or that the parties will obtain the required approvals of the board of directors, shareholders, third parties and / or regulatory or other authorities, as the case may be. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or to revise them to reflect the occurrence of unforeseen future events.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/94520.